GN
Insider
Gregory Norden
DirectorGregory Norden (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Royalty Pharma plc (RPRX). The largest single filing was $161K of RPRX (3,045 sh × $53.00, as filed), executed May 14.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$161K
shares × price, as filed
Last traded
May 14
Filed May 15
Median ADV $206.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
RPRXRecent filings
RPRXSALE
Royalty Pharma plc
View filing →
$161K3,045 sh × $53.00
Exec May 14
Filed May 15 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $1.2M
33,500 sh × $36.23
Exec Aug 11 2025
Filed Aug 11 2025 · 5:30 PM ET